Government Briefs

More Support For Innovations? Congress is impressed enough with the Small Business Innovation Research Program to think about giving the scheme an extra boost. Begun in 1982, the.program funnels money to small new high-tech businesses in order to speed the flow of potentially commercial ideas from the laboratory to the market. The funds come from a tax on the research budgets of all large federal science agencies including NASA, the Nuclear Regulatory Commission, and the Department of Defense.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Congress is impressed enough with the Small Business Innovation Research Program to think about giving the scheme an extra boost. Begun in 1982, the.program funnels money to small new high-tech businesses in order to speed the flow of potentially commercial ideas from the laboratory to the market. The funds come from a tax on the research budgets of all large federal science agencies including NASA, the Nuclear Regulatory Commission, and the Department of Defense. But there hasn’t been enough money to go around: this year, for example, NSF expects to fund only 160 of the 1500 proposals it has received (doling out a total of $19 million), even though reviewers thought that twice as many deserved support.

So, in one obscure item in last summers massive trade bill (P.L. 100-418), Congress asked the General Accounting Office to study the pros and cons of gradually raising from 1.25% to 3% each ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies